Abstract
Few proton magnetic resonance spectroscopy (1H spectroscopy) studies have investigated the dorsolateral prefrontal cortex (DLPFC), a key region in the pathophysiology of major depressive disorder (MDD). We used 1H spectroscopy to verify whether MDD patients differ from healthy controls (HC) in metabolite levels in this brain area. Thirty-seven unmedicated DSM-IV MDD patients were compared with 40 HC. Subjects underwent a short echo-time 1H spectroscopy examination at 1.5 T, with an 8-cm3 single voxel placed in the left DLPFC. Reliable absolute metabolite levels of N-acetyl aspartate (NAA), phosphocreatine plus creatine (PCr+Cr), choline-containing compounds (GPC+PC), myo-inositol, glutamate plus glutamine (Glu + Gln), and glutamate were obtained using the unsuppressed water signal as an internal reference. Metabolite levels in the left DLPFC did not statistically differ between MDD patients and HC. We found an interaction between gender and diagnosis on PCr+Cr levels. Male MDD patients presented lower levels of PCr+Cr than male HC, and female MDD patients presented higher levels of PCr+Cr than female HC. Moreover, length of illness was inversely correlated with NAA levels. These findings suggest that there is not an effect of diagnosis on the left DLPFC neurochemistry. Possible effects of gender on PCr+Cr levels of MDD patients need to be further investigated.
Original language | English |
---|---|
Pages (from-to) | 177-183 |
Number of pages | 7 |
Journal | Psychiatry Research - Neuroimaging |
Volume | 174 |
Issue number | 3 |
DOIs | |
Publication status | Published - 30 Dec 2009 |
Externally published | Yes |
Keywords
- Choline-containing compounds
- Glutamate
- Magnetic resonance spectroscopy
- Major depressive disorder
- N-acetyl aspartate
- Pathophysiology
- Phosphocreatine/creatine
- Prefrontal cortex